151 related articles for article (PubMed ID: 11248624)
1. Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer.
Batuello JT; Gamito EJ; Crawford ED; Han M; Partin AW; McLeod DG; ODonnell C
Urology; 2001 Mar; 57(3):481-5. PubMed ID: 11248624
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma.
Han M; Snow PB; Brandt JM; Partin AW
Cancer; 2001 Apr; 91(8 Suppl):1661-6. PubMed ID: 11309765
[TBL] [Abstract][Full Text] [Related]
3. Use of artificial neural networks in the clinical staging of prostate cancer: implications for prostate brachytherapy.
Gamito EJ; Stone NN; Batuello JT; Crawford ED
Tech Urol; 2000 Jun; 6(2):60-3. PubMed ID: 10798801
[TBL] [Abstract][Full Text] [Related]
4. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks.
Tewari A; Narayan P
J Urol; 1998 Aug; 160(2):430-6. PubMed ID: 9679892
[TBL] [Abstract][Full Text] [Related]
5. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Dec; 64(6):1165-70. PubMed ID: 15596191
[TBL] [Abstract][Full Text] [Related]
6. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
[TBL] [Abstract][Full Text] [Related]
7. Artificial neural network analysis for predicting pathological stage of clinically localized prostate cancer in the Japanese population.
Matsui Y; Egawa S; Tsukayama C; Terai A; Kuwao S; Baba S; Arai Y
Jpn J Clin Oncol; 2002 Dec; 32(12):530-5. PubMed ID: 12578902
[TBL] [Abstract][Full Text] [Related]
8. Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma.
Haese A; Epstein JI; Huland H; Partin AW
Cancer; 2002 Sep; 95(5):1016-21. PubMed ID: 12209685
[TBL] [Abstract][Full Text] [Related]
9. The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma.
Crawford ED; Batuello JT; Snow P; Gamito EJ; McLeod DG; Partin AW; Stone N; Montie J; Stock R; Lynch J; Brandt J
Cancer; 2000 May; 88(9):2105-9. PubMed ID: 10813722
[TBL] [Abstract][Full Text] [Related]
10. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
[TBL] [Abstract][Full Text] [Related]
11. A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy.
Han M; Snow PB; Epstein JI; Chan TY; Jones KA; Walsh PC; Partin AW
Urology; 2000 Dec; 56(6):994-9. PubMed ID: 11113746
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
[TBL] [Abstract][Full Text] [Related]
13. Artificial neural network for predicting pathological stage of clinically localized prostate cancer in a Taiwanese population.
Tsao CW; Liu CY; Cha TL; Wu ST; Sun GH; Yu DS; Chen HI; Chang SY; Chen SC; Hsu CY
J Chin Med Assoc; 2014 Oct; 77(10):513-8. PubMed ID: 25175002
[TBL] [Abstract][Full Text] [Related]
14. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen and Gleason score to predict prostate cancer stage.
Poulakis V; Witzsch U; De Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
J Urol; 2004 Oct; 172(4 Pt 1):1306-10. PubMed ID: 15371829
[TBL] [Abstract][Full Text] [Related]
15. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
16. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
[TBL] [Abstract][Full Text] [Related]
17. Artificial neural network model to predict biochemical failure after radical prostatectomy.
Porter C; O'Donnell C; Crawford ED; Gamito EJ; Errejon A; Genega E; Sotelo T; Tewari A
Mol Urol; 2001; 5(4):159-62. PubMed ID: 11790277
[TBL] [Abstract][Full Text] [Related]
18. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
Blute ML; Bergstralh EJ; Partin AW; Walsh PC; Kattan MW; Scardino PT; Montie JE; Pearson JD; Slezak JM; Zincke H
J Urol; 2000 Nov; 164(5):1591-5. PubMed ID: 11025711
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of
Cantiello F; Gangemi V; Cascini GL; Calabria F; Moschini M; Ferro M; Musi G; Butticè S; Salonia A; Briganti A; Damiano R
Urology; 2017 Aug; 106():139-145. PubMed ID: 28438628
[TBL] [Abstract][Full Text] [Related]
20. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer recurrence after radical prostatectomy.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Eur Urol; 2004 Nov; 46(5):571-8. PubMed ID: 15474265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
